EE200300321A - Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal - Google Patents

Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal

Info

Publication number: EE200300321A
Authority: EE; Estonia
Prior art keywords: infertility treatment; maturation during; endometrial maturation; during infertility; antigenic antigens
Prior art date: 2001-01-09

Application number

EEP200300321A

Other languages

English (en)

Inventor

Hegele-Hartung Christa

Hess-Stumpp Holger

M. Beier Henning

Krusche Claudia

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-09

Filing date

2002-01-09

Publication date

2003-10-15

2001-03-09 Priority claimed from US09/801,925 external-priority patent/US20020143000A1/en

2002-01-09 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2003-10-15 Publication of EE200300321A publication Critical patent/EE200300321A/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Reproductive Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

EEP200300321A 2001-01-09 2002-01-09 Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal EE200300321A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US75628601A	2001-01-09	2001-01-09
US09/801,925 US20020143000A1 (en)	2001-01-09	2001-03-09	Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
PCT/IB2002/001764 WO2002067910A2 (en)	2001-01-09	2002-01-09	The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Publications (1)

Publication Number	Publication Date
EE200300321A true EE200300321A (et)	2003-10-15

Family

ID=27116200

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300321A EE200300321A (et)	2001-01-09	2002-01-09	Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal

Country Status (25)

Country	Link
US (1)	US20040152684A1 (et)
EP (1)	EP1365765B1 (et)
JP (1)	JP2004520411A (et)
CN (1)	CN1244329C (et)
AR (1)	AR032390A1 (et)
AT (1)	ATE367817T1 (et)
AU (1)	AU2002253488B2 (et)
BG (1)	BG107977A (et)
BR (1)	BR0206367A (et)
CA (1)	CA2433776A1 (et)
CZ (1)	CZ20031864A3 (et)
DE (1)	DE60221359T2 (et)
DK (1)	DK1365765T3 (et)
EE (1)	EE200300321A (et)
ES (1)	ES2290284T3 (et)
HK (1)	HK1065953A1 (et)
HR (1)	HRP20030628A2 (et)
HU (1)	HUP0302632A2 (et)
IL (1)	IL156729A0 (et)
MX (1)	MXPA03006156A (et)
NO (1)	NO20033125L (et)
NZ (1)	NZ526908A (et)
PL (1)	PL361689A1 (et)
SK (1)	SK8612003A3 (et)
WO (1)	WO2002067910A2 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102009034362A1 (de) *	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) *	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) *	2009-07-21	2011-02-10	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) *	2011-07-28	2013-01-31	Klaus Nickisch	Progesterone antagonists
EP3501533A1 (en) *	2014-12-22	2019-06-26	Ferring B.V.	Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
EP3214092A1 (en)	2016-03-04	2017-09-06	Bayer Pharma Aktiengesellschaft	Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3533175A1 (de) *	1985-09-13	1987-03-19	Schering Ag	Antigestagene zur verschiebung der endometrialen reifung
DE19706061A1 (de) *	1997-02-07	1998-08-13	Schering Ag	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) *	1998-12-23	2000-06-29	Schering Ag	Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen

2002
- 2002-01-09 EE EEP200300321A patent/EE200300321A/et unknown
- 2002-01-09 AT AT02722637T patent/ATE367817T1/de not_active IP Right Cessation
- 2002-01-09 EP EP02722637A patent/EP1365765B1/en not_active Expired - Lifetime
- 2002-01-09 BR BR0206367-0A patent/BR0206367A/pt not_active IP Right Cessation
- 2002-01-09 DK DK02722637T patent/DK1365765T3/da active
- 2002-01-09 CA CA002433776A patent/CA2433776A1/en not_active Abandoned
- 2002-01-09 NZ NZ526908A patent/NZ526908A/en unknown
- 2002-01-09 HU HU0302632A patent/HUP0302632A2/hu unknown
- 2002-01-09 SK SK861-2003A patent/SK8612003A3/sk unknown
- 2002-01-09 CN CNB028061462A patent/CN1244329C/zh not_active Expired - Fee Related
- 2002-01-09 AR ARP020100053A patent/AR032390A1/es unknown
- 2002-01-09 IL IL15672902A patent/IL156729A0/xx unknown
- 2002-01-09 WO PCT/IB2002/001764 patent/WO2002067910A2/en not_active Application Discontinuation
- 2002-01-09 AU AU2002253488A patent/AU2002253488B2/en not_active Ceased
- 2002-01-09 DE DE60221359T patent/DE60221359T2/de not_active Expired - Fee Related
- 2002-01-09 ES ES02722637T patent/ES2290284T3/es not_active Expired - Lifetime
- 2002-01-09 JP JP2002567278A patent/JP2004520411A/ja active Pending
- 2002-01-09 CZ CZ20031864A patent/CZ20031864A3/cs unknown
- 2002-01-09 MX MXPA03006156A patent/MXPA03006156A/es unknown
- 2002-01-09 PL PL36168902A patent/PL361689A1/xx not_active Application Discontinuation
2003
- 2003-07-08 BG BG107977A patent/BG107977A/bg unknown
- 2003-07-08 NO NO20033125A patent/NO20033125L/no not_active Application Discontinuation
- 2003-08-04 HR HR20030628A patent/HRP20030628A2/hr not_active Application Discontinuation
- 2003-12-30 US US10/747,060 patent/US20040152684A1/en not_active Abandoned
2004
- 2004-11-11 HK HK04108894A patent/HK1065953A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL361689A1 (en)	2004-10-04
JP2004520411A (ja)	2004-07-08
CZ20031864A3 (en)	2004-03-17
WO2002067910A2 (en)	2002-09-06
AR032390A1 (es)	2003-11-05
BG107977A (bg)	2004-08-31
MXPA03006156A (es)	2003-09-16
NO20033125D0 (no)	2003-07-08
CN1244329C (zh)	2006-03-08
HK1065953A1 (en)	2005-03-11
WO2002067910A3 (en)	2003-02-06
NZ526908A (en)	2005-07-29
HUP0302632A2 (hu)	2003-11-28
DE60221359T2 (de)	2008-04-17
HRP20030628A2 (en)	2005-06-30
ATE367817T1 (de)	2007-08-15
ES2290284T3 (es)	2008-02-16
BR0206367A (pt)	2003-12-23
IL156729A0 (en)	2004-02-08
AU2002253488B2 (en)	2007-02-15
NO20033125L (no)	2003-09-09
DE60221359D1 (de)	2007-09-06
CN1496263A (zh)	2004-05-12
DK1365765T3 (da)	2007-10-29
SK8612003A3 (en)	2004-03-02
EP1365765A2 (en)	2003-12-03
EP1365765B1 (en)	2007-07-25
US20040152684A1 (en)	2004-08-05
CA2433776A1 (en)	2002-09-06

Publication	Publication Date	Title
HUP0204250A3 (en)	2005-06-28	Use of hiv-protein or -polynucleotide for vaccine produce
DK1446012T3 (da)	2013-10-14	Bakteriolytisk kombinationsterapi til behandling af tumorer
DE60138129D1 (de)	2009-05-07	Apparat zur behandlung von zähnen
NO20031218D0 (no)	2003-03-17	Kombinasjonsterapi for behandling av autoimmunsykdommer ved anvendelse av B-celle reduserende/immunregulerende antistoff kombinasjon
HUP0300099A3 (en)	2004-10-28	Vaccine for the treatment of artherosclerosis
EP1428828A4 (en)	2008-09-03	PROCESS FOR THE PRODUCTION OF ALKOXYSILANES
AU1167602A (en)	2002-05-06	Methods of therapy for hiv infection
GB0030918D0 (en)	2001-01-31	Activation of voice-controlled apparatus
EP1463495A4 (en)	2005-11-16	AGENTS AND METHODS FOR TREATING CANCER
EE200300321A (et)	2003-10-15	Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal
HUP0401392A3 (en)	2012-09-28	Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
NO20033506D0 (no)	2003-08-07	Parasittdrepende preparater og fremgangsmåter for anvendelse
DE60203207D1 (de)	2005-04-21	Zange zur orthodontischen Behandlung
NO20032789L (no)	2003-08-18	Apparat for lipolyse for estetisk behandling
EP1416795A4 (en)	2004-09-15	COMPOSITIONS AND METHODS OF TREATING DISEASES OF MITOCHONDRIA
ZA200306122B (en)	2004-11-08	The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment.
GB0124124D0 (en)	2001-11-28	Methods of treatment
GB0029573D0 (en)	2001-01-17	Activation of voice-controlled apparatus
EE200200415A (et)	2003-12-15	FSH kasutamine viljatuse raviks
DE60005566D1 (de)	2003-10-30	Pyranoindole zur glaukombehandlung
EE200200410A (et)	2003-12-15	Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
AU2001261260A8 (en)	2009-07-30	Methods for accelerated desensitization of teeth
EA200200927A1 (ru)	2003-04-24	Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления
NO20025765L (no)	2003-01-08	Kombinasjonssett for behandling av malaria
HK1064947A1 (en)	2005-02-08	Use of non-feminizing estrogens as retinoprotecti ve agents for the treatment of glaucoma